Kamalinder K. Singh - Concepedia

Author

Kamalinder K. Singh

Shreemati Nathibai Damodar Thackersey Women's University ORCID

Also Known As

Aparna Palshetker, K K Singh, K Singh, K. K. Singh, K. Singh, K.K. Singh, Kamalinder K Singh, Kamalinder K. Singh, Kamalinder Singh, Kamalinder. K. Singh

122

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Shreemati Nathibai Damodar Thackersey Women's University University of Lancashire Panjab University Freie Universität Berlin Post Graduate Institute of Medical Education and Research

About

Kamalinder K. Singh is an author at Shreemati Nathibai Damodar Thackersey Women's University specializing in medicine, pharmacology, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	1K
2	Engineering	13	15	699
3	Allergy	2	2	121
4	Public Health	1	1	25
5	Biochemistry	1	1	87

Kamalinder K. Singh

Publications

Citations

H-Index

Page 1

	Year	Citations
Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine Kamalinder K. Singh, Sharvani K. Vingkar International Journal of Pharmaceutics Lipid AnalysisNanomedicinePharmaceutical ScienceLipid PreparationActive Ingredient	2007	207
Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A Pallavi V. Pople, Kamalinder K. Singh AAPS PharmSciTech Lipid PreparationTopical FormulationMedicineSolid Lipid NanoparticlesTopical Drug	2006	184
Production & stability of stavudine solid lipid nanoparticles—From lab to industrial scale Ranjita Shegokar, Kamalinder K. Singh, Rainer Müller International Journal of Pharmaceutics NanoparticlesLipid AnalysisChemistryLipid ChemistryIndustrial Scale	2010	117
Development and evaluation of colloidal modified nanolipid carrier: Application to topical delivery of tacrolimus Pallavi V. Pople, Kamalinder K. Singh European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineEngineeringPharmaceutical NanotechnologyTopical Delivery	2011	110
Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis Pallavi V. Pople, Kamalinder K. Singh International Journal of Pharmaceutics AllergyAtopic DermatitisImmunologySkin AllergySkin Pharmacology	2010	109
Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation Ranjita Shegokar, Kamalinder K. Singh International Journal of Pharmaceutics NanomedicineEngineeringVivo EvaluationMedicineAntiviral Drug Development	2011	101
Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: Systematic development, characterization and evaluation Rajneet Kaur Khurana, Arvind K. Bansal, Sarwar Beg, International Journal of Pharmaceutics Lipid PreparationBiochemistrySystematic DevelopmentNano-drug DeliveryBiopharmaceutical Attributes	2016	87
Impact of liquid lipid on development and stability of trimyristin nanostructured lipid carriers for oral delivery of resveratrol Chahinez Houacine, David R. Adams, Kamalinder K. Singh Journal of Molecular Liquids Lipid PreparationNanomedicineEngineeringLipid CarriersOral Delivery	2020	81
Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation:<i>in vitro</i>and<i>in vivo</i>study Vandita Kakkar, Indu Pal Kaur, Amrit Pal Kaur, Drug Development and Industrial Pharmacy NanoparticlesNanotherapeuticsEngineeringBiomedical EngineeringDermatology	2018	72
Improving the biopharmaceutical attributes of mangiferin using vitamin E-TPGS co-loaded self-assembled phosholipidic nano-mixed micellar systems Rajneet Kaur Khurana, Balan Louis Gaspar, Gail Welsby, Drug Delivery and Translational Research	2018	62

Page 1